Amy Wolbeck, V.P. Regulatory Affairs & Qlty at Intersect ENT, Inc. (XENT), sold 8,000 shares at $23.06 ($184K) on 2015-03-11, disclosed to the SEC on 2015-03-13.
Scheduled sale ($184k) by V.P. Regulatory Affairs & Qlty under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| XENT | SELL | 2015-05-11 | $2K | — | Filing → |
| XENT | SELL | 2015-04-15 | $420K | — | Filing → |
| XENT | SELL | 2015-02-13 | $177K | — | Filing → |